IBS is the most common GI disorder seen in clinical practice. Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits in the absence of any organic disorder. Symptoms may include bloating, diarrhea or constipation. The nature and severity of symptoms vary widely between patients and may vary with time.
Currently it is useful to classify irritable bowel syndrome into several subtypes according to clinical presentation. These are useful for guiding the approach to therapy. The Rome IV Criteria are used to make the diagnosis which is based on the presence of intermittent pain with change in bowel frequency and consistency. These are:
Suspect IBS when a patient reports chronic recurrent abdominal pain and constipation or diarrhoea and bloating and is otherwise healthy.
90% of the human bodies seretonin is contained in the gastrointestinal tract. Seretonin has been implicated in the altered motor and sensory function observed in irritable bowel syndrome. 5HT4 and 5HT3 receptors are the major seretonin receptors in the bowel. Activation of 5HT3 receptors leads to improvement in:
Medical research has shown that gut dysbiosis refers to an imbalance in the composition of the gut microbiome, where harmful microbes outnumber or disrupt the beneficial ones (probiotics). This imbalance can impair the normal functions of the gut, such as digestion, nutrient absorption, and immune regulation. In the context of irritable bowel syndrome (IBS), dysbiosis may lead to increased intestinal permeability (“leaky gut”), inflammation, and abnormal communication between the gut and the brain. These changes can trigger or worsen hallmark IBS symptoms like bloating, abdominal pain, diarrhoea, and constipation. Certain microbial byproducts can also affect gut motility and sensitivity, further contributing to the chronic discomfort experienced by IBS sufferers.
A good doctor patient relationship is integral to the management of IBS. This includes counselling about the disease entity of IBS and reassurance of the benign nature of IBS which will help the patient’s self esteem and relieve anxiety. In addition, a healthy balanced diet and lifestyle is always of benefit in the long- term management of IBS.
The aim with dietary fibre supplementation is to start low and go slow as too much fibre will often lead to excessive bloating in C-IBS. The aim is 20g daily of soluble fibre.
The normal colon contains around 200ml of bowel gas. However certain foods can lead to excess production of gas by colonic bacteria related to their sugar content.
Natural laxatives may be useful – licorice, rhubarb, prunes, figs and fresh fruit.
Step 1 – Diagnose Dysbiosis by ordering the Gut Rehab Stool Test from www.bestgutmedical.com
Step 2 – Make and appointment to see Dr Froomes to interpret the test and commence a gut microiome repair program
or
Step 2 – Purchase your IBS-D or IBS-C Repair 4 Program from www.bestgutmedical.com and do it yourself.